Actively Recruiting
The Analgesic Efficacy of Pericapsular Nerve Group (PENG) Block in Patients Undergoing Primary Total Hip Arthoplasty:
Led by Diakonie-Klinikum Stuttgart · Updated on 2024-08-16
110
Participants Needed
1
Research Sites
51 weeks
Total Duration
On this page
Sponsors
D
Diakonie-Klinikum Stuttgart
Lead Sponsor
U
University Hospital Tuebingen
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of this study is to investigate the analgesic efficacy of the pericapsular nerve group (PENG) block during the implantation of hip endoprostheses. The study is designed as a prospective randomized double-blind study and the study participants were randomized into 2 arms and either 20 ml ropivacaine 0.5% (verum group) or 20 ml physiological saline solution (placebo group) will be applied.
CONDITIONS
Official Title
The Analgesic Efficacy of Pericapsular Nerve Group (PENG) Block in Patients Undergoing Primary Total Hip Arthoplasty:
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Planned cementless hip total endoprosthesis operation for primary coxarthrosis using minimally invasive anterolateral approach with Taperloc stem and Plamafit cup implant system
- Patient capable of giving consent
- Informed consent has been obtained
- Age greater than 18 years
You will not qualify if you...
- Refusal to participate in the study
- Regular use of opioids
- Known chronic pain symptoms
- Infections in the area of the puncture site
- Contraindications to ropivacaine
- Contraindications to metamizole
- Contraindications to postoperative analgesia with diclofenac
- Secondary forms of osteoarthritis with deformities such as high-grade dysplasia or conditions after trauma or childhood hip diseases
- Spinopelvic imbalance or spinal canal stenosis
- Previous operations on the hip or pelvis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Diakonie-Klinikum Stuttgart
Stuttgart, Baden-Wurttemberg, Germany, 70176
Actively Recruiting
Research Team
R
Rainer Meierhenrich, Prof. Dr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here